No Ice? No Problem: Vaccines successfully endure African heat

A trial using 15,000 vials of MenAfriVac  has successfully shown that the vaccines can survive the ‘last leg’ of the vaccine’s journey in nothing more than a picnic cooler. The trial, published today in Vaccine, examined the effects of this approach, called a  ‘controlled temperature chain‘ (CTC), on a drive across Benin to vaccinate against  meningococcal bacterium Neisseria meningitidis group A back in …